Cargando…
Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
BACKGROUND: Preoperative capecitabine-based chemoradiotherapy (CRT) is feasible for the treatment of resectable locally advanced rectal cancer (LARC). To try to improve efficacy, we conducted a phase II study in which the epidermal growth factor receptor-targeting monoclonal antibody cetuximab was a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472951/ https://www.ncbi.nlm.nih.gov/pubmed/23077464 http://dx.doi.org/10.2478/v10019-012-0030-2 |